Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant HIPEC in High-Risk Colorectal Cancer
NCT02575859Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2006
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cisplatin, mitomycin c in colorectal cancer (CRC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jan 2006; status: completed.
02
Drugs
cisplatinmitomycin c
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02575859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575859.